Active Ingredient History

  • Now
Fosbretabulin is a microtubule destabilizing experimental drug, a type of vascular-targeting agent, a drug designed to damage the vasculature of cancer tumours causing central necrosis. It is a derivative of combretastatin. It is formulated as the salts fosbretabulin disodium and fosbretabulin tromethamine.   Wikipedia

More Chemistry
1-(3,4,5-trimethoxyphenyl)-2-(3'-hydroxy-4'-methoxyphenyl)ethene | 2-methoxy-5-((z)-2-(3,4,5-trimethoxyphenyl)vinyl)phenyl dihydrogen phosphate | 3,4,5-trimethoxy-3'-hydroxy-4'-methoxystilbene | ca4dp | combretastatin a4 | combretastatin a-4 | combretastatin a-4 disodium phosphate | combretastatin a-4 phosphate | combretastatin a4 phosphate | crc 87-09 | crc-98-09 | deoxycombretastatin a-4 | fosbretabulin | fosbretabulin disodium | fosbretabulin tromethamine | isocombretastatin a-4 | nsc 817373 | nsc-817373 | phenol, 2-methoxy-5-((1z)-2-(3,4,5-trimethoxyphenyl)ethenyl)-,1-(dihydrogen phosphate) | phenol, 2-methoxy-5-((z)-2-(3,4,5-trimethoxyphenyl)ethenyl)-, dihydrogen phosphate | zybrestat


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue